main content start
Tradjenta (linagliptin) is a type 2 diabetes oral medication in the DPP-4 inhibitor class of drugs that slows the inactivation of GLP-1, a compound in the body that lowers blood glucose levels. It lowers blood glucose by slowing the inactivation of GLP-1, a compound in the body that lowers blood glucose levels.
Tradjenta is approved for adults with type 2 diabetes.
- Tradjenta is use to improve blood glucose management in adults with type 2 diabetes.
- It is not for treating type 1 diabetes.
- Tradjenta may be taken with or without food with a usual dose of 5 mg taken by mouth once a day.
- Common side effects may include headache or cold-like symptoms.
Tradjenta Specs
Key specification
Generic Name
Linagliptin
Drug Class
DPP-4 inhibitors
General Information
Product Name
Tradjenta
Product Type
Oral Medications
Brand
BOEHRINGER INGELHEIM
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
